Pharmafile.com’s weekly COVID-19 news round-up
September 16, 2020Research and Development COVID, COVID-19 vaccine, coronavirus
The coronavirus news this week focuses on AstraZeneca’s vaccine candidate, as global trials for itsmuch-hyped vaccine were halted after an …
Lilly’s baricitinib/remdesivir combo lowers recovery time in hospitalised COVID-19 patients, according to new data
September 15, 2020Manufacturing and Production, Research and Development COVID-19, Eli Lilly, pharma, remdesivir
Eli Lilly has unveiled promising new data from a study investigating the efficacy of baricitinib when combined with with Gilead’s …
MSD partners up with Seattle Genetics in two oncology development deals potentially worth over $4bn
September 15, 2020Manufacturing and Production, Sales and Marketing MSD, Seattle Genetics, deal, pharma
MSD has signed two new oncology-based deals with Seattle Genetics which together could be worth up to around $4.4 billion. …
Shionogi launches Fetcroja in the UK for aerobic Gram-negative bacteria infections
September 15, 2020Manufacturing and Production
Shionogi has announced the launch of its new antibiotic in the UK for the treatment of infections due to aerobic …
UK Government’s Chief Scientific Adviser “told off” for advocating for early lockdown
September 15, 2020Manufacturing and Production
Sir Patrick Vallance, the Chief Scientific Adviser to the UK Government, was “told off” for advocating for an early lockdown …
Avantor Clinical Services helps clinical trials stay on track
September 15, 2020Manufacturing and Production
Biopharma and pharmaceutical companies developing treatments and vaccines have long faced operational challenges that cost time and money while draining …
Oncology research in the age of COVID-19
September 14, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CAR T, CAR-T, Cancer, feature, pharma
Matt Fellows investigates the new challenges facing the oncology space and explores the strategies that can carry it through the disruptive …
AstraZeneca and Oxford Uni’s COVID-19 vaccine trial resumes following safety review
September 14, 2020Research and Development, Sales and Marketing AstraZeneca, COVID-19, Oxford University, Vaccine
After sparking a wave of concern through industry and mainstream media with the news it had halted international studies investigating …
Gilead scoops up Immunomedics in deal worth $21 billion
September 14, 2020Sales and Marketing Gilead, Immunomedics, acquisition, pharma
The Board of Directors from both companies have unanimously agreed for Gilead to acquire Immunomedics for $88 per share in …
World Health Organization reports highest one-day rise in COVID-19 infections
September 14, 2020Sales and Marketing WHO, coronavirus
The World Health Organization has recorded the largest daily rise of coronavirus infection worldwide since the pandemic began. This was …
Pfizer CEO says company’s COVID-19 vaccine will be available this year if FDA approves the candidate by October
September 14, 2020Sales and Marketing Pfizer, Pfizer vaccine, Vaccine
Albert Bourla, the CEO of Pfizer, has said that the company’s vaccine for COVID-19 could be used by the general …
Trump signs order to start a process to lower US drug prices
September 14, 2020Sales and Marketing Donald Trump drug prices, drug prices
President Trump has signed an executive order that could cut drug prices by tying them to similar prices in countries …
Targazyme snaps up new CEO
September 11, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Targazyme, appointment
Experienced industry executive James Caggiano has been named as the new head of Californian biotech Targazyme, who will take up …
NICE U-turns to approve AstraZeneca’s Tagrisso in two new lung cancer indications
September 11, 2020Medical Communications, Sales and Marketing AstraZeneca, NICE, Tagrisso
NICE has announced the recommendation of AstraZeneca’s Tagrisso (osimertinib) for routine use on the NHS in England and Wales in …
Roche and Novartis fined a collective €444 million in France for abusive practices
September 11, 2020Medical Communications eye medicine, eye treatment
Novartis and Roche have been fined €444 million in France for abusive practices the companies implemented to push Lucentis over …
NICE opts to reject Celgene’s Revlimid for newly diagnosed multiple myeloma after an autologous stem cell transplant
September 11, 2020Medical Communications, Sales and Marketing Celgene, NICE, Revlimid
It has emerged that NICE has opted to reject Celgene’s Revlimid (lenalidomide) for the maintenance of newly diagnosed multiple myeloma …
FDA sends warning letters to websites illegally selling opioids
September 11, 2020Medical Communications
The FDA has issued warning letters to 17 websites for illegally selling unapproved or misbranded opioids. This is due to …
Top Ten most popular articles on Pharmafile.com this week
September 11, 2020Medical Communications COVID-19, coronavirus, vaccines
The top 10 news stories this week largely cover COVID-19 vaccines, as hundreds of thousands of people in China have …
FDA approves GlaxoSmithKline’s Trelegy for treating asthma
September 10, 2020Research and Development Ashtma, inhaler
The FDA has approved a new indication of Trelegy Ellipta for the treatment of asthma and patients with chronic obstructive …
AstraZeneca Chief Executive says vaccine is still possible this year
September 10, 2020Research and Development AstraZeneca, Oxford Vaccine, Vaccine, coronavirus vaccine, vaccines
Pascal Soriot, Chief Executive of AstraZeneca, said that the company’s vaccine could still be available this year, despite the clinical …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
